Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Appendix S1 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)
  1. Home
  2. Publications
  3. Supplementary Appendix S1 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)

Supplementary Appendix S1 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)

Authors:
  • KAKeiju Aokage
    Keiju Aokage
  • SKShohei Koyama
    Shohei Koyama
  • SKShogo Kumagai
    Shogo Kumagai
  • KNKotaro Nomura
    Kotaro Nomura
  • YSYoshihisa Shimada
    Yoshihisa Shimada
  • KYKiyotaka Yoh
    Kiyotaka Yoh
  • MWMasashi Wakabayashi
    Masashi Wakabayashi
  • MFMiki Fukutani
    Miki Fukutani
  • HFHideki Furuya
    Hideki Furuya
  • TMTomohiro Miyoshi
    Tomohiro Miyoshi
  • KTKenta Tane
    Kenta Tane
  • JSJoji Samejima
    Joji Samejima

Open Access
Publisher website
Google Scholar
  • 16 December 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.28032412
Abstract
Supplementary Appendix S1: EAST_ENERGY_Protocol_v7.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • LUNG CANCER
  • TUMOR MICROENVIRONMENT
  • IMMUNE CELLS AND THE MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.